In Partnership with:
5498 Stories, most recent news story added Tue Nov 10, 2:45 am ET
A drug industry group on Monday urged the U.S. Food and Drug Administration to adopt a universal safety symbol for Internet content containing FDA-approved information about a medicine or medical device.
Analysts sees upside in two Ariad drugs while FDA delays decision on Xenoport drug.
Batesville, Miss.-based Dunlap & Kyle Co. Inc., which owns and operates Gateway Tire and Service Centers, has internally transferred six acres of ....
WASHINGTON -(Dow Jones)- Hospira Inc. (HSP) is recalling certain dietary supplements and anesthesia products because some may contain stainless steel particles that could restrict blood flow and lead to heart attacks or death.
The short supply of H1N1 vaccine has scam artists out to capitalize on people's fears.
Today Dr. Lawrence Deyton, who at 57 still goes by his childhood nickname of "Bopper," is the nation's first anti-smoking czar. He directs a new agency in the federal Food and Drug Administration — the Center for Tobacco Products — that is writing rules to govern the previously unregulated tobacco industry.
This year, the U.S. Food and Drug Administration (FDA) mandated Bayer—maker of the birth control pill, Yaz—to run a correction to its Yaz marketing that cost some $20-million. Bayer must also submit its ads to the agency for approval resulting from a legal settlement obtained by some state attorneys general and the agency. Now, Yaz and [...]
A courtroom bid to block implementation of the FDA tobacco-regulation law filed by a top cigarette company has been denied by a federal judge, the Associated Press reported Nov. 5.
The U.S. Food and Drug Administration Center for Veterinary Medicine recently granted a supplemental label for MGA® 200 (melengestrol acetate) Premix and MGA® 500 Liquid Premix to be fed at a higher level with Rumensin® (monensin).
Cutaneous T-cell lymphoma affects about 1,500 Americans annually The U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lymphoma (CTCL).
STOCKHOLM, Sweden -- Diamyd Inc., Pittsburgh, PA, USA, a wholly-owned subsidiary of Diamyd Medical, Stockholm Sweden, announces today that the United States Department of Veterans Affairs has awarded a $1.84 million grant to support the development of Diamyd's Nerve Targeting Drug Delivery System for Diabetic Neuropathic Pain.
U.S. health officials are dealing with shortages and production delays of H1N1 vaccine, but stand by the choice not to opt for vaccine boosters, called adjuvants, that could stretch supply of H1N1 vaccine, but are not licensed in the United States.
( Porter Novelli ) Shire PLC announced the availability of INTUNIV in pharmacies nationwide for the treatment of ADHD in children and adolescents ages 6-17. INTUNIV, a once-daily formulation of guanfacine, is the first and only nonscheduled alpha-2A receptor agonist approved for the treatment of ADHD. In clinical trials, INTUNIV provided significant efficacy across the spectrum of ADHD symptoms ...
Updated code is a model for state, city, county, tribal, territorial agencies and industry. The Food and Drug Administration today announced the publication of the new FDA Food Code, a model code and reference document that provides a scientifically sound technical and legal basis for regulating the retail and food service segment of the food industry. The 2009 FDA Food Code is a key component ...
JERUSALEM----Teva Pharmaceutical Industries Ltd. announced today it is seeking to amend its existing complaint against Momenta Pharmaceuticals, Inc./Sandoz Inc. to include patent infringement of three additional patents related to the characterization of COPAXONE® .
Momentum Europe 2009 -- EMC® Corporation , the world leader in information infrastructure solutions, today announced EMC My Documentum®, a family of products that allows everyone in the organization to utilize EMC Documentum enterprise content management functionalities directly from common desktop applications and familiar interfaces.
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters